← Leaderboards
Jenny Downs
University Of Colorado Denver
$1,173,421
Attributed
$4,693,682
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,693,682 · 1
By mechanism
U01$4,693,682 · 1
Top collaborators
- Timothy A Benke7 shared
- Helen M Leonard7 shared
- Eric D Marsh7 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Ronald J Sokol$193,385,254
- Stanley J Szefler$16,550,328
- E David Crawford$6,974,306
- Randi J Hagerman$23,937,829
- Timothy C Kennedy$560,508
Others in their field
Other Emerging Leaders on “Outcome Measure”
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- James Dale Berry · Brigham And Women'S Hospital$25,163,692
- Abraham Aizer Brody · New York University School Of Medicine$23,525,790
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$21,289,866
- Priyamvada Acharya · Duke University$20,941,151
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
Research focus
Outcome MeasureNovel TherapeuticsImpaired CognitionMotor DisorderMotor ImpairmentNational Institute Of Neurological Disorders And StrokeGene TherapyGeneticModificationMeasurementEpileptic EncephalopathiesClinical Trial ReadinessClinical TrialsMulti-Institutional Clinical TrialAnimal ModelGenesCyclin-Dependent KinasesClinical Outcome MeasuresBiological MarkersEvoked PotentialsElectroencephalographyEnsureBiomarker ValidationPathogenicity
Grant awards (7)
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$782,432
U01 · FY2025 · NS
Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder - Supplement$77,998
U01 · FY2025 · NS
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$859,629
U01 · FY2024 · NS
Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder$78,000
U01 · FY2024 · NS
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$902,257
U01 · FY2023 · NS
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$924,239
U01 · FY2022 · NS
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$1,069,127
U01 · FY2021 · NS